CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE2343.55-34.9 (-1.47 %)
PREV CLOSE () 2378.45
OPEN PRICE () 2412.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4600
TODAY'S LOW / HIGH ()2337.00 2449.00
52 WK LOW / HIGH ()1910.1 3050
NSE2347.50-35.95 (-1.51 %)
PREV CLOSE() 2383.45
OPEN PRICE () 2408.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2347.50 (842)
VOLUME 527892
TODAY'S LOW / HIGH() 2335.20 2453.05
52 WK LOW / HIGH ()1901.05 3054.8
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1991

Management Info :

Ramesh Juneja - Chairman Rajeev Juneja - Managing Director

Registered Office :

Address : 208,Okhla Industrial Estate,Phase - 111,
New Delhi,
Delhi-110020

Phone : 011-46846700

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
03Apr Mankind Pharma informs about complianc
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Reg..
01Mar Mankind Pharma informs about disclosure
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Ob..
10Feb Mankind Pharma informs about outcome o
Mankind Pharma has informed that the Board appointed Committee of Indepe..
15Jan Mankind Pharma informs about update
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Ob..
08Jan Resignation of Director
Interalia, considered, noted and approved the following matters: 1. Res..
Financials
in Millions
QTR Dec 24 ANNUAL 24
Net Profit4163.818234.11
Gross Profit 5242.5 22595.68
Operating Profit 8107.525917.44
Net Sales 23965.792648.09
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 29413.45 (1.68%)
M.Cap ( in Cr)
62501.53
Neuland Laboratories (BSE)
 11201.80 (2.31%)
M.Cap ( in Cr)
14371.79
Sanofi India (BSE)
 6171.25 (3.38%)
M.Cap ( in Cr)
14212.77
Astrazeneca Pharma I (BSE)
 8061.90 (2.24%)
M.Cap ( in Cr)
20154.75
Glaxosmithkline Phar (BSE)
 2728.95 (5.89%)
M.Cap ( in Cr)
46230.06
Shareholding Pattern
PROMOTERS 72.71%
MUTUAL FUNDS/UTI 7.83%
NON-INSTITUTION 2.9%
FI/BANKS/INSURANCE 2.21%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX74227.081089.18 (1.49%)
NIFTY22535.85374.25 (1.69%)
Dow Jones 37965.60-349.26 (-0.91%)
Nasdaq 15603.2615.47 (0.10%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI